Feed Preview

Pharmacogenetics & Pharmacogenomics

Pharmacogenetics & Pharmacogenomics diagram by Nova et al.
Nova et al.

Pharmacogenetics and pharmacogenomics (pgx) are rapidly growing fields that aim to elucidate the genetic basis for the interindividual differences in drug response. Here is the latest research on pharmacogenetics and pharmacogenomics.

Top 20 most recent papers
Scientific Reports

Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial

Scientific ReportsNovember 28, 2019
Magdalena Gómez-SilvaRafael Baltazar Reyes León-Cachón

Pan-organ model integration of metabolic and regulatory processes in type 1 diabetes

bioRxivNovember 30, 2019
Marouen Ben Guebila, Ines Thiele
The Journal of Infectious Diseases

Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population

The Journal of Infectious DiseasesNovember 27, 2019
Michele D. SpringJason W Bennett
Pacific Symposium on Biocomputing

PGxMine: Text mining for curation of PharmGKB

Pacific Symposium on BiocomputingDecember 6, 2019
Jake LeverRuss Biagio Altman
Molecular Psychiatry

Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs

Molecular PsychiatryDecember 2, 2019
Alexander B NiculescuAndrew J. Saykin
Genome Biology

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers

Genome BiologyNovember 26, 2019
Jason Kyungha SaJeong-Won Lee
Clinical Pharmacology and Therapeutics

Pharmacovigilance 2030: Invited Commentary for the January 2020 "Futures" Edition of Clinical Pharmacology and Therapeutics

Clinical Pharmacology and TherapeuticsNovember 22, 2019
Peter R ArlettGuido Rasi
The Pharmacogenomics Journal

Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)

The Pharmacogenomics JournalDecember 5, 2019
Amelia FilippelliCiro Gallo

Pharmacogenomics in the clinic: genetic polymorphism contributing to venlafaxine-associated heart failure

PharmacogenomicsNovember 1, 2019
Harleen SinghThomas B Barrett
Pacific Symposium on Biocomputing

Frequency of ClinVar Pathogenic Variants in Chronic Kidney Disease Patients Surveyed for Return of Research Results at a Cleveland Public Hospital

Pacific Symposium on BiocomputingDecember 6, 2019
Dana C CrawfordWilliam S Bush
The Pharmacogenomics Journal

Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients

The Pharmacogenomics JournalDecember 3, 2019
Merve Demirbugen OzHalit Sinan Süzen
Pacific Symposium on Biocomputing

Translational Bioinformatics: Biobanks in the Precision Medicine Era

Pacific Symposium on BiocomputingDecember 6, 2019
Marylyn DeRiggi RitchieJu Han Kim
Journal of Clinical Lipidology

JCL roundtable: Pediatric lipidology

Journal of Clinical LipidologyDecember 1, 2019
Amy L PetersonJohn R Guyton
Briefings in Bioinformatics

RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data

Briefings in BioinformaticsDecember 3, 2019
Qun DongYun-Peng Zhang
International Journal of Molecular Sciences

Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder

International Journal of Molecular SciencesNovember 30, 2019
Claudia PisanuAlessio Squassina
Pharmacogenomics and Personalized Medicine

Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare

Pharmacogenomics and Personalized MedicineOctober 30, 2019
Jyothsna GiriPedro J Caraballo
Personalized Medicine

Genomic testing is best integrated into clinical practice when it is actionable

Personalized MedicineDecember 4, 2019
Rachele M Hendricks-SturrupJason L Vassy
Clinical Pharmacology and Therapeutics

PharmVar and the Landscape of Pharmacogenetic Resources

Clinical Pharmacology and TherapeuticsNovember 23, 2019
Andrea GaedigkTeri E Klein

Impact of CYP2C19 genotype and drug interactions on voriconazole plasma concentrations: a spain pharmacogenetic-pharmacokinetic prospective multicenter study

PharmacotherapyNovember 29, 2019
Sara Blanco DoradoAnxo Fernández-Ferreiro
Clinical Pharmacology and Therapeutics

Pharmacometrics and Systems Pharmacology 2030

Clinical Pharmacology and TherapeuticsNovember 23, 2019
France MentréPing X Zhao

See more papers from this feed

Related Feeds

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2019 Meta ULC. All rights reserved